Clinical Trial Update: Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the dose safety, tolerability, and immunogenicity of a new smallpox vaccine in adults without previous smallpox vaccination; the study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Smallpox vaccine (Sanofi Pasteur)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Smallpox | Phase 2 | Status: TERMINATED